FILTER
LATEST INTERVIEWS
Jeffrey Nau
PRESIDENT & CEO, OYSTER POINT PHARMA
"Our mission is to bring novel and transformative therapies to the anterior (front) chamber of the eye, particularly for the treatment of ocular surface disease."
Shuang Liu
CEO & FOUNDER, CONSYNANCE THERAPEUTICS
"Although each rare disease impacts a small population, the rare disease population is estimated to be 10% of the total population, meaning 25-30 million Americans have at least one rare condition."
Vinod Agnihotri
MANAGING DIRECTOR ASEAN AND HEAD OF MPP, APAC LANXESS
"The strong recovery in the automotive sector has contributed significantly to our growth, and so did our engineering materials segment, which includes both our high-performance materials and urethane systems business units."
Marcela Hernando
MINISTER OF MINING, GOVERNMENT OF CHILE
“We would like exploration to open the door to new developments, so we aim to make the necessary regulatory changes to increase legal certainty for those who are willing to invest in exploration.”
Mario Theurl
MANAGING DIRECTOR, ZÜBLIN STRABAG CHILE
“I am convinced that our appreciation towards our great teams with open and transparent communication and our customer centricity are key to success.”
Jorge Granda
COO, AK DRILLING INTERNATIONAL
AK Drilling discusses the current state of the drilling sector in Peru. (Spanish interview)
José Luis Lara
GERENTE GENERAL, LARA CONSULTING
Lara Consulting provides an overview of its expertise in tailings management. (Spanish interview)
Takayuki Inagaki
MANAGING DIRECTOR, MITSUI CHEMICALS ASIA PACIFIC (MCAP)
"MCAP is committed to continue our support to Mitsui Chemicals Group in moving towards a solution-based business model to respond to social and environmental challenges."
Jay Roberts & Robert Fremeau
PRESIDENT AND CEO & CHIEF SCIENTIFIC OFFICER, VYANT BIO
"At Vyant Bio we are reinventing how drugs are discovered for complex neurological and neurodegenerative disorders by applying a human-first approach."
Andrea Pfeifer
CO-FOUNDER & CEO, AC IMMUNE
"AC Immune is combining diagnostics and therapeutics, and it has developed the tools to enable detection and clearance of specific pathological proteins underlying neurodegenerative diseases."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Mexico Chemicals 2024
In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.
In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
